Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Join the Eastern England Secure Data Environment (SDE) and Health Innovation East Midlands for the launch of a new webinar series demonstrating how the Eastern England SDE can support research and innovation by providing secure access to de-identified NHS patient data for analysis.
*Guest article by LimestoneGrey. If you would like to submit an article or blog post please email [email protected].
by Philippa Clark, Director of Business Development, One Nucleus
Help build the future of drug safety monitoring
Drug-induced toxicity remains one of the biggest causes of drug-development delay, clinical failure and patient harm. Current monitoring is often insensitive, organ-specific and reliant on damage becoming clinically apparent. We think there is a better way.
For UK life science companies, entering the US market means navigating FDA regulatory strategies, legal structures, tax, hiring and routes to market, often, all at the same time.
Salary: £39,000 - £42,150 per annum depending on qualifications and experience. A starting salary of £40,100 is guaranteed for candidates who can evidence their PhD certificate on appointment.
Contract: 36 months, full-time
Location: John Innes Centre, Norwich, UK
Closing date: 26 October 2026
Reference: 1006209
Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation in Clinical Study
— Proprietary algorithm optimized tablet composition and dose level for clinical study in healthy participants —
— Interim results suggest significant potential for developing optimized formulations with fewer clinical rounds —